Biohaven (BHVN) Depreciation and Depletion (2021 - 2026)

Biohaven (BHVN) reported Depreciation and Depletion of $708000.0 for Q1 2026, down 30.25% on a YoY basis from $1.0 million in Q1 2025, and down 26.25% sequentially from $960000.0 in Q4 2025.

Biohaven (BHVN) Depreciation and Depletion (2021 - 2026) Analysis & Trends

Biohaven (BHVN) has 6 years of Depreciation and Depletion data on file, last reported at $708000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Depreciation and Depletion fell 30.25% year-over-year to $708000.0; the trailing twelve-month figure through Mar 2026 stood at $3.8 million (down 4.1% YoY), and the FY2025 full-year result was $4.1 million, up 5.53% from the prior year.
  • Depreciation and Depletion retreated to $708000.0 in Q1 2026, from $960000.0 in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $1.1 million in Q3 2025 to a low of $209000.0 in Q1 2022.
  • A 5-year average of $794176.5 and a median of $941000.0 in 2024 frame the typical range for Depreciation and Depletion.
  • Across the five-year window, Depreciation and Depletion soared 273.84% in 2022 and tumbled 30.25% in 2026, its largest moves.
  • Tracing BHVN's Depreciation and Depletion over 5 years: stood at $643000.0 in 2022, then soared by 47.43% to $948000.0 in 2023, then gained by 6.01% to $1.0 million in 2024, then fell by 4.48% to $960000.0 in 2025, then declined by 26.25% to $708000.0 in 2026.
  • Business Quant data shows BHVN's Depreciation and Depletion at $708000.0 in Q1 2026, $960000.0 in Q4 2025, and $1.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 196,658.72
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 39.39 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 2.20 Mn
10 Biohaven 2.16 Bn 1.81 Bn - 708,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 708,000.00
Mar 31, 2026 708,000.00
Dec 31, 2025 960,000.00
Dec 31, 2025 960,000.00
Sep 30, 2025 1.11 Mn
Sep 30, 2025 1.11 Mn
Jun 30, 2025 1.06 Mn
Jun 30, 2025 1.06 Mn
Mar 31, 2025 1.02 Mn
Mar 31, 2025 1.02 Mn
Dec 31, 2024 1.01 Mn
Dec 31, 2024 1.01 Mn
Sep 30, 2024 1.00 Mn
Sep 30, 2024 1.00 Mn
Jun 30, 2024 977,000.00
Jun 30, 2024 977,000.00
Mar 31, 2024 941,000.00
Mar 31, 2024 941,000.00
Dec 31, 2023 948,000.00
Dec 31, 2023 948,000.00